Strybol Pharma (SRL)

Active

VAT

BE 0459.503.747

Address

Donkstraat 120a

9990 Maldegem

Established

18-12-1996

Principal activity

Retail trade of pharmaceutical products in specialised stores

Try for free

Crisis resilience of Strybol Pharma

Which companies are best armed against current economic trends and the energy crisis?

2022		2021		2020		2019
Profit/Loss	€47,923	-77%	€212,591	614%	-€41,345	21%	-€52,407
Equity	€1,353,767	4%	€1,305,843	19%	€1,093,252	-4%	€1,134,597
Gross margin	€988,771	-18%	€1,199,697	36%	€882,156	2%	€862,063
Employees	8,9 FTE	-16%	10,6 FTE	-6%	11,3 FTE	-3%	11,7 FTE

Publications in the Belgian Official Journal for Strybol Pharma

Type	Date	Pdf	Subject
	14-08-2019		Designation - Goal - Modification Legal Form - Rubric Restructuring (Fusion, Split, Transfer of Asse… (NL)
	14-06-2019		Rubric Restructuring (Fusion, Split, Transfer of Assets, etc...) (NL)
	02-07-2014		Goal - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	06-02-2014		Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	06-01-2012		Articles of Association (Translation, Coordination, Other Modifications, …) (NL)

Sources

Frequently asked questions

What is the VAT number of Strybol Pharma?

The VAT number of Strybol Pharma is BE0459503747.

When was Strybol Pharma founded?

Strybol Pharma was founded on 18-12-1996.

What is the address of Strybol Pharma?

The current registered office of Strybol Pharma is located at Donkstraat 120a, 9990 Maldegem.

When was the last time Strybol Pharma filed their annual financial statements?

The most recent financial statements of Strybol Pharma were filed on 07-07-2023. You can view them here.

How many employees does Strybol Pharma have?

There are 8,9 FTEs working at Strybol Pharma according to the staff figures in the most recent financial statements.

What is the annual turnover of Strybol Pharma?

At the time of its most recent financial statements, Strybol Pharma did not publish any turnover figures. Strybol Pharma reported a gross margin of €988,770.88.